Clinical Trials Logo
  1. Home
  2. Cardiomyopathy, Hypertrophic
  3. NCT02862600

Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure

Cardiomyopathy, Hypertrophic Clinical Trial

Official title:
A Phase 2, Multi-Center, Open-Label, Ascending Dose Study on the Efficacy, Safety and Tolerability of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure With Preserved Left Ventricular Function

Clinical Trial Summary

The purpose of this study is to evaluate the effect of perhexiline on exercise performance (efficacy) and safety in patients with hypertrophic cardiomyopathy and moderate-to-severe heart failure following dosing for 16 weeks.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02862600
Study type Interventional
Source Heart Metabolics Limited
Contact Heart Metabolics Call Center
Phone 1-800-206-2434
Email info@heartmetabolics.com
Status Recruiting
Phase Phase 2
Start date August 2016
Completion date August 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT00253682 - Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers N/A
Recruiting NCT06034405 - Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Terminated NCT04222101 - Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy N/A
Recruiting NCT05646056 - A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk
Completed NCT00692991 - Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures N/A
Withdrawn NCT04905173 - Comparison of Squat-to-Stand Maneuver With Amyl Nitrite, Valsalva, and Exercise Stress Echocardiography in Inducing Latent Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy N/A
Recruiting NCT03251287 - Nitrite in Hypertrophic Cardiomyopathy (HCM) Study Phase 1
Recruiting NCT01165749 - Exercise Study Including Patients With Hypertrophic Cardiomyopathy N/A
Recruiting NCT03057002 - UTSW HP [13-C] Pyruvate Injection in HCM
Recruiting NCT02696135 - The Chinese Hypertrophic Cardiomyopathy Study(CHCS)
Recruiting NCT03040947 - MRI Sequence and Imaging Protocol Development
Active, not recruiting NCT02417311 - Individualized Early Risk Assessment for Heart Diseases
Completed NCT03225001 - PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - Nested Registry 3/Valve-in-Valve N/A
Recruiting NCT05524077 - Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia N/A
Completed NCT04164732 - Study of Efficacy of Oral Sacubitril/Valsartan in Adult Patients With Non-obstructive Hypertrophic Cardiomyopathy Phase 2
Recruiting NCT06112743 - A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy Phase 4
Completed NCT00001871 - Study of Muscle Abnormalities in Patients With Specific Genetic Mutations N/A
Completed NCT00001459 - Analysis of Heart Muscle Function in Patients With Heart Disease and Normal Volunteers N/A
Completed NCT00005251 - Genetic Analysis of Familial Hypertrophic Cardiomyopathy N/A
Active, not recruiting NCT05556343 - A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy Phase 2